Softbank Group Corp »

Abcellera Biologics shares owned by Softbank Group Corp

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Softbank Group Corp from 13F filings

Historical chart of Softbank Group Corp investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Softbank Group Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Softbank Group Corp

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.2M 345k 3.42

More positions owned by Softbank Group Corp

Metropcs Communications (TMUS)
Intel Corporation (INTC)
Symbotic Class A Com (SYM)
Twenty One Cap Com Shs Cl A (XXI)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Inter & Co I Class A Co (INTR)
Klarna Group SHS (KLAR)
Webtoon Entmt (WBTN)
Tempus Ai Cl A (TEM)
Nu Hldgs L Ord Shs Cl (NU)
Vtex Shs Cl A (VTEX)
Chime Finl Com Shs Cl A (CHYM)
Qxo Com New (QXO)
Lemonade (LMND)
Recursion Pharmaceuticals In Cl A (RXRX)

View all positions for Softbank Group Corp

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Capital World Investors
Ubs Global Asset Management Americas
Two Sigma Investments
Two Sigma Advisers
Goldman Sachs Group
Arrowpoint Asset Management
BlackRock
Millennium Management
Renaissance Technologies
Susquehanna International
UBS Group
Guardian Partners
Driehaus Capital Management
Jane Street

View all funds holding Abcellera Biologics